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Summary of human Vibrio isolates reported to CDC, 2006
Infection with toxigenic Vibrio cholerae serogroups O1 and O139, the causative agents of cholera, has 
been a reportable disease in the United States for many years.  In addition, CDC maintains a database of 
reported infections with all species of Vibrio from humans in order to obtain reliable information on 
illnesses associated with the range of Vibrio species.  This information has been used to educate 
consumers about the health risks of seafood, as well as to help determine host, food, and environmental 
risk factors.  
The Cholera and Other Vibrio Illness Surveillance System (COVIS) was initiated by the Food and Drug 
Administration (FDA), CDC, and the Gulf Coast states (Alabama, Florida, Louisiana, Mississippi, and 
Texas) in 1988.  Participating health officials collect clinical data, information about underlying illness, 
history of seafood consumption and exposure to seawater in the 7 days before illness, and conduct 
tracebacks of implicated oysters.  Reporting has expanded and since 1997, many other states have also 
reported Vibrio isolates (Figure 1).  However, only toxigenic V. cholerae O1 and O139 were nationally 
notifiable; thus the number of Vibrio isolates is likely greater than reported.  CDC serotypes all V.
parahaemolyticus isolates received from state health departments, and screens for cholera toxin 
production and the O1, O139, and O141 serogroups in V. cholerae isolates. 
This report summarizes human Vibrio infections during 2006 reported by states to CDC.  Results are 
presented in two categories: V. cholerae isolates that produce cholera toxin (referred to as toxigenic 
Vibrio cholerae), and all other Vibrio isolates, including those V. cholerae isolates that do not produce 
cholera toxin.  Results are presented separately for Gulf Coast states versus other states consistency with 
previous reports.  Additionally, results are presented by anatomic site of isolation.  It is important to note 
that isolation of some Vibrio species from a patient with illness does not necessarily indicate causation.  
While many Vibrio species are well-recognized pathogens, the status of V. damsela, V. furnissii, V.
metschnikovii, and V. cincinnatiensis as enteric or wound pathogens is less clear. 
In June 2006, the Council of State and Territorial Epidemiologists adopted a resolution to add all Vibrio
species infections (vibriosis) to the list of nationally notifiable diseases reported to the National 
Notifiable Diseases Surveillance System (NNDSS).  Reporting of vibriosis is in addition to and distinct 
from reporting of cholera currently conducted through NNDSS.  The position statement, “National 
Reporting for non-cholera Vibrio Infections (Vibriosis),” can be found at 
http://www.cste.org/PS/2006pdfs/PSFINAL2006/06-ID-05FINAL.pdf.  In addition to reporting through 
NNDSS, CDC requests that states collect information using the standard surveillance form for COVIS 
available at http://www.cdc.gov/foodborneoutbreaks/. 
An outbreak of V. parahaemolyticus involving a total of 177 confirmed and probable cases associated 
with consumption of raw shellfish occurred during the summer in 20061.  A total of 62 reports of 
confirmed V. parahaemolyticus outbreak-related cases were reported to COVIS from 10 states (Alaska, 
California, Connecticut, Georgia, New Jersey, New York, Oregon, Texas, Utah, and Washington).  
Dates of onset ranged from May 30 to September 20.  Of the 62 reports received, 60 (97%) cases 
reported consuming oysters, of which 73% reporting eating raw oysters.  Among patients, for whom
information was known, 3% were hospitalized and no deaths were reported.  Several oyster growing 






Isolates of toxigenic Vibrio cholerae
In 2006, eight patients with toxigenic V. cholerae O1 (cholera), two patients with toxigenic V. cholerae 
O141, and one patient with V. cholerae O75 were reported (Table 1).  Of the eight cholera cases, four 
patients were hospitalized and no deaths were reported.  Infection was acquired through international 
travel for four sporadic cases (three cases acquired infection while traveling in India and one case while 
traveling in Bangladesh).  Of those who acquired infection while in India, two were vegetarians with no 
recreational water exposure, and the third reported eating fresh fruits and vegetables washed in local 
water.  The patient that traveled to Bangladesh reported consuming fish while abroad.  All four 
domestically-acquired infections occurred in residents of Louisiana who reported having eaten crab.  
Two of the patients obtained crab from friends or relatives who caught the crab in Louisiana.  A third 
case purchased crab from a local distributor and the fourth could not remember where the crab was 
obtained. The pulsed field gel electrophoresis (PFGE) patterns of the isolates from all four patients were 
indistinguishable from each other by SfiI enzyme.  When compared with the national V. cholerae 
database, these four isolates were indistinguishable from isolates previously characterized as the Gulf
Coast strain by SfiI.  Further comparison using a second enzyme, NotI, revealed that these four isolates 
and previous Gulf Coast strains differed by one to three bands. 
One of the two patients with toxigenic V. cholerae O141 had traveled internationally to Morocco.  Her 
symptoms began during her trip although she did not seek medical attention until returning home.  No 
further risk information was reported.  The other case ate raw oysters domestically 1 day before 
symptom onset.  Two others who also ate the oysters reported diarrhea lasting for 1 day.   Previous cases 
of V. cholerae O141 have occurred in the United States2. 
The patient infected with V. cholerae O75 had traveled domestically to Miami where he consumed 
clams and raw oysters.  He presented at his primary care provider’s office 4 days after onset of vomiting, 
diarrhea, nausea, abdominal cramps, myalgias, and headache.  No treatment or hospitalization was 
required. 
Table 1: Isolates of toxigenic V. cholerae, 2006
State Age  Sex  Onset Exposure Serogroup 
California 27 F 5/2/2006 Travel in India V. cholerae O1
Illinois 58 M 6/25/2006 Travel in India V. cholerae O1
Louisiana 39 F 6/5/2006 Domestic (seafood)-Gulf Coast V. cholerae O1
Louisiana 60 F 6/20/2006 Domestic (seafood)-Gulf Coast V. cholerae O1
Louisiana 75 F 6/27/2006 Domestic (seafood)-Gulf Coast V. cholerae O1
Louisiana 60 F 7/31/2006 Domestic (seafood)-Gulf Coast V. cholerae O1
New Jersey 15 M 7/31/2006 Travel in India Inaba 
New York 46 M 5/21/2006 V. cholerae O1 Inaba 









Travel in Bangladesh 
10/22/2006 Domestic (seafood)-Gulf Coast V. cholerae O141
Tennessee 32 F 9/24/2006 Travel in Morocco V. cholerae O141 





Other Vibrio isolates (excluding toxigenic V. cholerae)  
In 2006, 744 Vibrio isolates from 718 patients were reported to the Cholera and Other Vibrio Illness 
Surveillance System (Tables 2 and 3).  Among patients for whom information was available, 215 (32%) 
of 665 were hospitalized and 36 (6%) of 649 died.  V. parahaemolyticus was isolated from 403 (56%) 
patients, and was the most frequently reported Vibrio species.  Of the patients infected with V. 
parahaemolyticus, 68 (18%) were hospitalized and 1 (<1%) died.  V. vulnificus was isolated from 99 
(14%) patients; 79 (85%) were hospitalized and 31 (35%) died.     
Table 2.  Number of Vibrio illnesses (excluding toxigenic V. cholerae) by species, complications, and site 
of isolation in patients from Gulf Coast states, 2006. 
Complications1 Site of Isolation 
Vibrio Species Patients Hospitalized Deaths Isolates Stool Wound Other2
N (%) n/N (%) n/N (%) N (%) 
V. alginolyticus 28 (17) 2/24 (8) 0/25 (0) 28 (16) 0 1 13 
V. cholerae  
(non-toxigenic) 3 14 (8) 6/13 (46) 1/11 (9) 14 (8) 7 0 3 
V. damsela 1 (1) 0/1 (0) 0/1 (0) 1 (1) 1 0 0 
V. fluvialis 7 (4) 3/7 (43) 0/7 (0) 7 (4) 3 2 2 
V. hollisae 4 (2) 4/4 (100) 0/4 (0) 4 (2) 4 0 0 
V. mimicus 7 (4) 4/7 (57) 0/7 (0) 7 (4) 5 1 0 
V. parahaemolyticus 42 (26) 14/37 (38) 1/39 (3) 42 (24) 22 15 2 
V. vulnificus 53 (32) 43/49 (88) 15/45 (33) 58 (33) 6 13 2 
Species not identified 2 (1) 0/2 (0) 0/2 (0) 2 (1) 0 1 1 
Other 1 (1) 0/0 (0) 0/0 (0) 1 (1) 0 0 1 












0 9 0 
Total 164 (100) 80/149 (54) 17/145 (12) 176 (100) 50 46 56 
1 Denominators indicate patients for whom information is known. 
2 Includes ear, sputum, urine, and other. 
3 Includes non-toxigenic V. cholerae O1 (1 isolate) and other non-toxigenic V. cholerae [non-O1 non-O139]
  (13 isolates). 
4  V. parahaemolyticus and V. alginolyticus were isolated from two patients; V. parahaemolyticus, V. vulnificus, and an other
Vibrio species were isolated from one patient; V. alginolyticus and an unidentified Vibrio species were isolated from one 






Table 3.  Number of Vibrio illnesses (excluding toxigenic V. cholerae) by species, complications, and site 
of isolation in patients from non-Gulf Coast states, 2006  
Complications1 Site of Isolation 
Vibrio Species Patients Hospitalized Deaths Isolates Stool Wound Other2
N (%) n/N (%) n/N (%) N (%) 
V. alginolyticus 54 (10) 11/49 (22) 1/49 (2) 54 (10) 0 3 26 
V. cholerae  
(non-toxigenic) 3 29 (5) 11/27 (41) 2/24 (8) 30 (5) 15 4 6 
V. damsela 1 (0) 0/1 (0) 0/1 (0) 1 (0) 0 1 0 
V. fluvialis 23 (4) 9/21 (43) 0/22 (0) 23 (4) 17 3 2 
V. metschnikovii 1 (0) 1/1 (100) 0/0 (0) 1 (0) 1 0 0 
V. hollisae 4 (1) 4/4 (100) 0/4 (0) 4 (1) 4 0 0 
V. mimicus 5 (1) 1/5 (20) 0/5 (0) 5 (1) 4 0 1 
V. parahaemolyticus 361 (65) 52/336 (15) 0/329 (0) 362 (64) 337 12 10 
V. vulnificus 46 (8) 36/44 (82) 16/43 (37) 50 (9) 3 18 2 
Species not identified 20 (4) 7/19 (37) 0/17 (0) 20 (3) 6 6 7 
Other 3 (1) 1/3 (33) 0/3 (0) 3 (1) 2 1 0 













3 2 3 
Total 554 (100) 135/516 (26) 19/504 (4) 568 (100) 396 43 72 57 
1 Denominators indicate patients for whom information is known. 
2 Includes ear, sputum, urine, and other. 
3 Includes non-toxigenic V. cholerae O1 (1 isolate), and other non-toxigenic V. cholerae [non-O1 non-O139] (28 isolates).
4 V. parahaemolyticus and V. vulnificus were isolated from two patients; V. alginolyticus and an other Vibrio species were
isolated from one patient; V. cholerae non-O1, non-O139, V. cholerae O1, and V.cholerae O139 were isolated from one 
patient; V. alginolyticus and V. parahaemolyticus were isolated from one patient; V. fluvialis and an other Vibrio species were 






Of the 718 cases in 2006, CDC received 164 (23%) reports of Vibrio illness from Gulf Coast states, 
286 (40%) from Pacific Coast states, 199 (28%) from Atlantic Coast states (excluding Florida, which 
is included with Gulf Coast states), and 69 (10%) from inland states (Figure 1).  The most frequent 
Vibrio species reported from Gulf Coast states were V. vulnificus (32%), V. parahaemolyticus (25%), 
V. alginolyticus (17%), and non-toxigenic V. cholerae (9%). The most frequent Vibrio species 
reported from non-Gulf Coast states were V. parahaemolyticus (65%), V. alginolyticus (10%), V. 
vulnificus (8%), and non-toxigenic V. cholerae (5%). 
Figure 1.  Number of patients with Vibrio isolates (excluding toxigenic V. cholerae), by state, 2006 
(N=718 patients in 39 states) 
Anatomic Site of Isolation
Among the 744 Vibrio isolates from all states, 446 (60%) were from stool, 89 (12%) from blood, and 
128 (17%) from wounds.  Thirty-six (5%) isolates were obtained from the ear, of which 30 (83%) were 
V. alginolyticus.  An additional 45 isolates (6%) were from urine, sputum, or other site. V. 
parahaemolyticus was the species most frequently isolated from stool (359 [80%] of 446 isolates from
stool); V. vulnificus was the species most frequently isolated from blood (64 [72%] of 89 isolates from









































The number of patients from whom Vibrio species was isolated had a clear seasonal peak during the 
summer months (Figure 2). The greatest frequency of cases occurred during July for Gulf Coast states 
and non-Gulf Coast states.
Figure 2.  Number of patients with Vibrio isolates (excluding toxigenic V. cholerae), by month of 
illness onset or specimen isolation, Gulf Coast states vs. other states, 2006 (N=718). 
Exposures
One hundred four (14%) patients reported having a wound either before or during exposure to Vibrio. Of 
those, 97 (93%) reported having skin exposed to a body of water, 32 (31%) reported handling seafood, 
and 21 (20%) reported contact with marine wildlife.  Excluding patients with wound infections, among 
the 465 for whom a food history was available, 437 (94%) reported eating seafood in the 7 days before 
illness onset. Among the 208 who reported eating a single seafood item (Table 4), 60% ate oysters 
(79% of whom consumed them raw), 11% ate finfish, 10% ate shrimp. International travel in the 7 days 





































Table 4.  Seafood exposure among patients with foodborne Vibrio infection (excluding toxigenic V. cholerae) who reported eating a single seafood 
item in the week before illness onset, 2006 (N=208)
Crustaceans 
Oysters Clams Mussels Shrimp Lobster Crayfish Other Shellfish1 Finfish2 Total
Ate (%) 138 (60) 14 (6) 2 (1) 24 (10) 3 (1%) 
Mollusks 
Crab 
20 (9%) 0 (0%) 4 (2%) 26 (11%) 231 
% Ate raw 79 64 50 13 0 0 0 25 11 55 
1 Other shellfish reported: prawns, squid, and sushi. 





For reports where laboratory confirmation was available, the state public health laboratory identified 
216 (98%) of 221 human Vibrio isolates, excluding V. cholerae. CDC received 147 isolates of V. 
parahaemolyticus from 141 patients. Of these, 41 (30%) from nine states were serotype O4:K12 
(Alaska, Colorado, Connecticut, Georgia, Nevada, New Mexico, New York State, Oregon, and 
Washington); 14 (10%) isolates from eleven public health jurisdictions were of the pandemic clone 
serotype O3:K6 (Arizona, Colorado, Georgia, Louisiana, Maryland, Montana, New York City, New 
York State, Texas, Virginia, and Wisconsin); 7 (5%) isolates from six states were serotype O4:K63
(Arizona, Colorado, Mississippi,  New York, Louisiana, and Washington); and the remaining 79 
isolates were one of 32 serotypes.  Twelve possible pandemic clones (thermostable direct homolysin 
positive/thermostable direct related hemolysin negative) include four 01:Kuk, two 03:Kuk, and one 
each of 01:K25, 03:K29, 04:K8, 04:K37, 06:K18, and 08:K41. 
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